These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15015612)

  • 1. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial.
    Piao BK; Wang YX; Xie GR; Mansmann U; Matthes H; Beuth J; Lin HS
    Anticancer Res; 2004; 24(1):303-9. PubMed ID: 15015612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study.
    Schumacher K; Schneider B; Reich G; Stiefel T; Stoll G; Bock PR; Hanisch J; Beuth J
    Anticancer Res; 2003; 23(6D):5081-7. PubMed ID: 14981970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
    Semiglazov VF; Stepula VV; Dudov A; Schnitker J; Mengs U
    Anticancer Res; 2006; 26(2B):1519-29. PubMed ID: 16619567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study.
    Bar-Sela G; Wollner M; Hammer L; Agbarya A; Dudnik E; Haim N
    Eur J Cancer; 2013 Mar; 49(5):1058-64. PubMed ID: 23218588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of ML-1 standardized mistletoe extract on the quality of life in head and neck cancer patients].
    Steuer-Vogt MK; Bonkowsky V; Scholz M; Fauser C; Licht K; Ambrosch P
    HNO; 2006 Apr; 54(4):277-86. PubMed ID: 16132877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative epidemiological cohort study.
    Beuth J; Schneider B; Schierholz JM
    Anticancer Res; 2008; 28(1B):523-7. PubMed ID: 18383896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems of randomized studies in complementary medicine demonstrated in a study on mistletoe treatment of patients with breast cancer].
    Gerhard I; Abel U; Loewe-Mesch A; Huppmann S; Kuehn JJ
    Forsch Komplementarmed Klass Naturheilkd; 2004 Jun; 11(3):150-7. PubMed ID: 15249749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial.
    Friess H; Beger HG; Kunz J; Funk N; Schilling M; Büchler MW
    Anticancer Res; 1996; 16(2):915-20. PubMed ID: 8687151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
    Pelzer F; Tröger W; Nat DR
    J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
    Semiglasov VF; Stepula VV; Dudov A; Lehmacher W; Mengs U
    Anticancer Res; 2004; 24(2C):1293-302. PubMed ID: 15154663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
    Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen TR; Weyhenmeyer R; Lentzen H
    Arzneimittelforschung; 1998 May; 48(5):497-502. PubMed ID: 9638318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood and tissue eosinophilia, mistletoe lectin antibodies and quality of life in a breast cancer patient undergoing intratumoral and subcutaneous mistletoe therapy].
    Kröz M; Schad F; Matthes B; Pickartz H; Girke M
    Forsch Komplementarmed Klass Naturheilkd; 2002 Jun; 9(3):160-7. PubMed ID: 12119512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immunomodulation and safety of standardized aqueous mistletoe extract PS76A2 in tumor patients treated for 48 weeks.
    Dohmen W; Breier M; Mengs U
    Anticancer Res; 2004; 24(2C):1231-7. PubMed ID: 15154652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.
    Goebell PJ; Otto T; Suhr J; Rübben H
    J Urol; 2002 Jul; 168(1):72-5. PubMed ID: 12050495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant simultaneous mistletoe chemotherapy in breast cancer--influence on immunological parameters, quality of life and tolerability].
    Loewe-Mesch A; Kuehn JJ; Borho K; Abel U; Bauer C; Gerhard I; Schneeweiss A; Sohn C; Strowitzki T; v Hagens C
    Forsch Komplementmed; 2008 Feb; 15(1):22-30. PubMed ID: 18334811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized and double-blind studies--demands and reality as demonstrated by two examples of mistletoe research.
    Rostock M; Huber R
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():18-22. PubMed ID: 15353898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.
    Huber R; Lüdtke R; Klassen M; Müller-Buscher G; Wolff-Vorbeck G; Scheer R
    Eur J Med Res; 2001 Sep; 6(9):399-405. PubMed ID: 11669085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models.
    Braun JM; Ko HL; Schierholz JM; Beuth J
    Anticancer Res; 2002; 22(6C):4187-90. PubMed ID: 12553054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.